Introduction
The Department of Clinical Oncology in collaboration with the Hospital Authority Department of Clinical Oncology at the Queen Mary Hospital runs an active oncology service in Queen Mary Hospital. As a tertiary referral center, the Department sees over 1500 new patients per year with all types of cancers. Multidisciplinary approach is employed and the Department works in close collaboration with the Department of Surgery, Department of Medicine, Department of Obstetrics & Gynecology, Department of Pathology, Department of Microbiology, and Department of Diagnostic Radiology in research and in providing clinical service. The Department also has close liaisons and academic exchange with oncology centers in other parts of China and in the Asia Pacific region.
The Department has a long tradition of research, publication and running clinical trials and is one of the renowned centers in the region, especially in treatment and research of nasopharyngeal carcinoma, other head and neck cancers, gynecological cancers, carcinoma of esophagus, carcinoma of breast, and colorectal cancers, using radiotherapy, chemotherapy and biological therapy.
There are 20 clinicians, 7 physicists, and 26 radiographers working in the Department. There are four linear accelerators, one stimulator and one high-dose-rate remote afterloading brachytherapy machine in the Department. Most of the treatment is administered as outpatient but the Department also runs an in-patient facility of 26 beds.
In addition to clinical service and research, the Department has teaching duties in the undergraduate curriculum, and takes up the supervision of MPhil, PhD students and overseas visiting fellows.
For basic bench-top research, the Laboratory of Cancer Genetics (LCG) is established and supported by generous donations from the Leung Kwok Tze Foundation.
The Laboratory of Cancer Molecular Genomics (LCMG) is newly established in 2009 with research areas focus on Esophageal and Nasopharyngeal Carcinoma.
